Most kids are enrolled in early education and child care programs. Seasonal influenza outbreaks are expected annually. Influenza can be severe, resulting in hospitalization or death of some children. Immunization against influenza is the best strategy to reduce infection and spread.

Market Analysis and Insights: Global Pediatric Influenza Treatment Market

The global Pediatric Influenza Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Pediatric Influenza Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pediatric Influenza Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pediatric Influenza Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pediatric Influenza Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pediatric Influenza Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pediatric Influenza Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Pediatric Influenza Treatment Market Report

Report Metric	Details
Report Name	Pediatric Influenza Treatment Market
CAGR	5%
Segment by Type	Antiviral Drug Antipyretic Neuraminidase inhibitor Others
Segment by Application	Hospitals Clinics Ambulatory Surgical Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc., NATCO Pharma Limited., NESHER PHARMS, Johnson & Johnsons Inc., Cipla, Hetero Pharma, Teva Pharmaceutical pvt. Ltd., Olainfarm JSC, Gilead Sciences, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pediatric Influenza Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Influenza Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pediatric Influenza Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Pediatric Influenza Treatment Market report?

Ans: The main players in the Pediatric Influenza Treatment Market are F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc., NATCO Pharma Limited., NESHER PHARMS, Johnson & Johnsons Inc., Cipla, Hetero Pharma, Teva Pharmaceutical pvt. Ltd., Olainfarm JSC, Gilead Sciences, Inc.

What are the Application segmentation covered in the Pediatric Influenza Treatment Market report?

Ans: The Applications covered in the Pediatric Influenza Treatment Market report are Hospitals, Clinics, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Pediatric Influenza Treatment Market report?

Ans: The Types covered in the Pediatric Influenza Treatment Market report are Antiviral Drug, Antipyretic, Neuraminidase inhibitor, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pediatric Influenza Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Antiviral Drug

1.2.3 Antipyretic

1.2.4 Neuraminidase inhibitor

1.2.5 Others

1.3 Market by Application

1.3.1 Global Pediatric Influenza Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pediatric Influenza Treatment Market Perspective (2019-2030)

2.2 Global Pediatric Influenza Treatment Growth Trends by Region

2.2.1 Pediatric Influenza Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Pediatric Influenza Treatment Historic Market Size by Region (2019-2024)

2.2.3 Pediatric Influenza Treatment Forecasted Market Size by Region (2025-2030)

2.3 Pediatric Influenza Treatment Market Dynamics

2.3.1 Pediatric Influenza Treatment Industry Trends

2.3.2 Pediatric Influenza Treatment Market Drivers

2.3.3 Pediatric Influenza Treatment Market Challenges

2.3.4 Pediatric Influenza Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Pediatric Influenza Treatment by Players

3.1.1 Global Pediatric Influenza Treatment Revenue by Players (2019-2024)

3.1.2 Global Pediatric Influenza Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Pediatric Influenza Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Pediatric Influenza Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Pediatric Influenza Treatment Market Concentration Ratio

3.4.1 Global Pediatric Influenza Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pediatric Influenza Treatment Revenue in 2023

3.5 Global Key Players of Pediatric Influenza Treatment Head office and Area Served

3.6 Global Key Players of Pediatric Influenza Treatment, Product and Application

3.7 Global Key Players of Pediatric Influenza Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pediatric Influenza Treatment Breakdown Data by Type

4.1 Global Pediatric Influenza Treatment Historic Market Size by Type (2019-2024)

4.2 Global Pediatric Influenza Treatment Forecasted Market Size by Type (2025-2030)

5 Pediatric Influenza Treatment Breakdown Data by Application

5.1 Global Pediatric Influenza Treatment Historic Market Size by Application (2019-2024)

5.2 Global Pediatric Influenza Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Pediatric Influenza Treatment Market Size (2019-2030)

6.2 North America Pediatric Influenza Treatment Market Size by Type

6.2.1 North America Pediatric Influenza Treatment Market Size by Type (2019-2024)

6.2.2 North America Pediatric Influenza Treatment Market Size by Type (2025-2030)

6.2.3 North America Pediatric Influenza Treatment Market Share by Type (2019-2030)

6.3 North America Pediatric Influenza Treatment Market Size by Application

6.3.1 North America Pediatric Influenza Treatment Market Size by Application (2019-2024)

6.3.2 North America Pediatric Influenza Treatment Market Size by Application (2025-2030)

6.3.3 North America Pediatric Influenza Treatment Market Share by Application (2019-2030)

6.4 North America Pediatric Influenza Treatment Market Size by Country

6.4.1 North America Pediatric Influenza Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Pediatric Influenza Treatment Market Size by Country (2019-2024)

6.4.3 North America Pediatric Influenza Treatment Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Pediatric Influenza Treatment Market Size (2019-2030)

7.2 Europe Pediatric Influenza Treatment Market Size by Type

7.2.1 Europe Pediatric Influenza Treatment Market Size by Type (2019-2024)

7.2.2 Europe Pediatric Influenza Treatment Market Size by Type (2025-2030)

7.2.3 Europe Pediatric Influenza Treatment Market Share by Type (2019-2030)

7.3 Europe Pediatric Influenza Treatment Market Size by Application

7.3.1 Europe Pediatric Influenza Treatment Market Size by Application (2019-2024)

7.3.2 Europe Pediatric Influenza Treatment Market Size by Application (2025-2030)

7.3.3 Europe Pediatric Influenza Treatment Market Share by Application (2019-2030)

7.4 Europe Pediatric Influenza Treatment Market Size by Country

7.4.1 Europe Pediatric Influenza Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Pediatric Influenza Treatment Market Size by Country (2019-2024)

7.4.3 Europe Pediatric Influenza Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Pediatric Influenza Treatment Market Size (2019-2030)

8.2 China Pediatric Influenza Treatment Market Size by Type

8.2.1 China Pediatric Influenza Treatment Market Size by Type (2019-2024)

8.2.2 China Pediatric Influenza Treatment Market Size by Type (2025-2030)

8.2.3 China Pediatric Influenza Treatment Market Share by Type (2019-2030)

8.3 China Pediatric Influenza Treatment Market Size by Application

8.3.1 China Pediatric Influenza Treatment Market Size by Application (2019-2024)

8.3.2 China Pediatric Influenza Treatment Market Size by Application (2025-2030)

8.3.3 China Pediatric Influenza Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Pediatric Influenza Treatment Market Size (2019-2030)

9.2 Asia Pediatric Influenza Treatment Market Size by Type

9.2.1 Asia Pediatric Influenza Treatment Market Size by Type (2019-2024)

9.2.2 Asia Pediatric Influenza Treatment Market Size by Type (2025-2030)

9.2.3 Asia Pediatric Influenza Treatment Market Share by Type (2019-2030)

9.3 Asia Pediatric Influenza Treatment Market Size by Application

9.3.1 Asia Pediatric Influenza Treatment Market Size by Application (2019-2024)

9.3.2 Asia Pediatric Influenza Treatment Market Size by Application (2025-2030)

9.3.3 Asia Pediatric Influenza Treatment Market Share by Application (2019-2030)

9.4 Asia Pediatric Influenza Treatment Market Size by Region

9.4.1 Asia Pediatric Influenza Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Pediatric Influenza Treatment Market Size by Region (2019-2024)

9.4.3 Asia Pediatric Influenza Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 F. Hoffmann-La Roche Ltd

11.1.1 F. Hoffmann-La Roche Ltd Company Details

11.1.2 F. Hoffmann-La Roche Ltd Business Overview

11.1.3 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Introduction

11.1.4 F. Hoffmann-La Roche Ltd Revenue in Pediatric Influenza Treatment Business (2019-2024)

11.1.5 F. Hoffmann-La Roche Ltd Recent Developments

11.2 GlaxoSmithKline Plc.

11.2.1 GlaxoSmithKline Plc. Company Details

11.2.2 GlaxoSmithKline Plc. Business Overview

11.2.3 GlaxoSmithKline Plc. Pediatric Influenza Treatment Introduction

11.2.4 GlaxoSmithKline Plc. Revenue in Pediatric Influenza Treatment Business (2019-2024)

11.2.5 GlaxoSmithKline Plc. Recent Developments

11.3 NATCO Pharma Limited.

11.3.1 NATCO Pharma Limited. Company Details

11.3.2 NATCO Pharma Limited. Business Overview

11.3.3 NATCO Pharma Limited. Pediatric Influenza Treatment Introduction

11.3.4 NATCO Pharma Limited. Revenue in Pediatric Influenza Treatment Business (2019-2024)

11.3.5 NATCO Pharma Limited. Recent Developments

11.4 NESHER PHARMS

11.4.1 NESHER PHARMS Company Details

11.4.2 NESHER PHARMS Business Overview

11.4.3 NESHER PHARMS Pediatric Influenza Treatment Introduction

11.4.4 NESHER PHARMS Revenue in Pediatric Influenza Treatment Business (2019-2024)

11.4.5 NESHER PHARMS Recent Developments

11.5 Johnson & Johnsons Inc.

11.5.1 Johnson & Johnsons Inc. Company Details

11.5.2 Johnson & Johnsons Inc. Business Overview

11.5.3 Johnson & Johnsons Inc. Pediatric Influenza Treatment Introduction

11.5.4 Johnson & Johnsons Inc. Revenue in Pediatric Influenza Treatment Business (2019-2024)

11.5.5 Johnson & Johnsons Inc. Recent Developments

11.6 Cipla

11.6.1 Cipla Company Details

11.6.2 Cipla Business Overview

11.6.3 Cipla Pediatric Influenza Treatment Introduction

11.6.4 Cipla Revenue in Pediatric Influenza Treatment Business (2019-2024)

11.6.5 Cipla Recent Developments

11.7 Hetero Pharma

11.7.1 Hetero Pharma Company Details

11.7.2 Hetero Pharma Business Overview

11.7.3 Hetero Pharma Pediatric Influenza Treatment Introduction

11.7.4 Hetero Pharma Revenue in Pediatric Influenza Treatment Business (2019-2024)

11.7.5 Hetero Pharma Recent Developments

11.8 Teva Pharmaceutical pvt. Ltd.

11.8.1 Teva Pharmaceutical pvt. Ltd. Company Details

11.8.2 Teva Pharmaceutical pvt. Ltd. Business Overview

11.8.3 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Introduction

11.8.4 Teva Pharmaceutical pvt. Ltd. Revenue in Pediatric Influenza Treatment Business (2019-2024)

11.8.5 Teva Pharmaceutical pvt. Ltd. Recent Developments

11.9 Olainfarm JSC

11.9.1 Olainfarm JSC Company Details

11.9.2 Olainfarm JSC Business Overview

11.9.3 Olainfarm JSC Pediatric Influenza Treatment Introduction

11.9.4 Olainfarm JSC Revenue in Pediatric Influenza Treatment Business (2019-2024)

11.9.5 Olainfarm JSC Recent Developments

11.10 Gilead Sciences, Inc.

11.10.1 Gilead Sciences, Inc. Company Details

11.10.2 Gilead Sciences, Inc. Business Overview

11.10.3 Gilead Sciences, Inc. Pediatric Influenza Treatment Introduction

11.10.4 Gilead Sciences, Inc. Revenue in Pediatric Influenza Treatment Business (2019-2024)

11.10.5 Gilead Sciences, Inc. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

F Hoffmann La Roche Ltd

GlaxoSmithKline PLC

Natco Pharma Limited

NESHER PHARMS

Johnson & Johnsons Inc.

Cipla Ltd

Hetero Pharma

Teva Pharmaceutical pvt. Ltd.

JSC

Olainfarm JSC

Gilead Sciences Inc

List of Tables

Table 1. Global Pediatric Influenza Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Antiviral Drug

Table 3. Key Players of Antipyretic

Table 4. Key Players of Neuraminidase inhibitor

Table 5. Key Players of Others

Table 6. Global Pediatric Influenza Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Pediatric Influenza Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Pediatric Influenza Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Pediatric Influenza Treatment Market Share by Region (2019-2024)

Table 10. Global Pediatric Influenza Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Pediatric Influenza Treatment Market Share by Region (2025-2030)

Table 12. Pediatric Influenza Treatment Market Trends

Table 13. Pediatric Influenza Treatment Market Drivers

Table 14. Pediatric Influenza Treatment Market Challenges

Table 15. Pediatric Influenza Treatment Market Restraints

Table 16. Global Pediatric Influenza Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Pediatric Influenza Treatment Revenue Share by Players (2019-2024)

Table 18. Global Top Pediatric Influenza Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Influenza Treatment as of 2023)

Table 19. Global Pediatric Influenza Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Pediatric Influenza Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Pediatric Influenza Treatment, Headquarters and Area Served

Table 22. Global Key Players of Pediatric Influenza Treatment, Product and Application

Table 23. Global Key Players of Pediatric Influenza Treatment, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Pediatric Influenza Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Pediatric Influenza Treatment Revenue Market Share by Type (2019-2024)

Table 27. Global Pediatric Influenza Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Pediatric Influenza Treatment Revenue Market Share by Type (2025-2030)

Table 29. Global Pediatric Influenza Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Pediatric Influenza Treatment Revenue Share by Application (2019-2024)

Table 31. Global Pediatric Influenza Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Pediatric Influenza Treatment Revenue Share by Application (2025-2030)

Table 33. North America Pediatric Influenza Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Pediatric Influenza Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Pediatric Influenza Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Pediatric Influenza Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Pediatric Influenza Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Pediatric Influenza Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Pediatric Influenza Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Pediatric Influenza Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Pediatric Influenza Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Pediatric Influenza Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Pediatric Influenza Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Pediatric Influenza Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Pediatric Influenza Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Pediatric Influenza Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Pediatric Influenza Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Pediatric Influenza Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Pediatric Influenza Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Pediatric Influenza Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Pediatric Influenza Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Pediatric Influenza Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Pediatric Influenza Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Pediatric Influenza Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Pediatric Influenza Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Pediatric Influenza Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Pediatric Influenza Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Pediatric Influenza Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 65. F. Hoffmann-La Roche Ltd Company Details

Table 66. F. Hoffmann-La Roche Ltd Business Overview

Table 67. F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Product

Table 68. F. Hoffmann-La Roche Ltd Revenue in Pediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 69. F. Hoffmann-La Roche Ltd Recent Developments

Table 70. GlaxoSmithKline Plc. Company Details

Table 71. GlaxoSmithKline Plc. Business Overview

Table 72. GlaxoSmithKline Plc. Pediatric Influenza Treatment Product

Table 73. GlaxoSmithKline Plc. Revenue in Pediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 74. GlaxoSmithKline Plc. Recent Developments

Table 75. NATCO Pharma Limited. Company Details

Table 76. NATCO Pharma Limited. Business Overview

Table 77. NATCO Pharma Limited. Pediatric Influenza Treatment Product

Table 78. NATCO Pharma Limited. Revenue in Pediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 79. NATCO Pharma Limited. Recent Developments

Table 80. NESHER PHARMS Company Details

Table 81. NESHER PHARMS Business Overview

Table 82. NESHER PHARMS Pediatric Influenza Treatment Product

Table 83. NESHER PHARMS Revenue in Pediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 84. NESHER PHARMS Recent Developments

Table 85. Johnson & Johnsons Inc. Company Details

Table 86. Johnson & Johnsons Inc. Business Overview

Table 87. Johnson & Johnsons Inc. Pediatric Influenza Treatment Product

Table 88. Johnson & Johnsons Inc. Revenue in Pediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 89. Johnson & Johnsons Inc. Recent Developments

Table 90. Cipla Company Details

Table 91. Cipla Business Overview

Table 92. Cipla Pediatric Influenza Treatment Product

Table 93. Cipla Revenue in Pediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 94. Cipla Recent Developments

Table 95. Hetero Pharma Company Details

Table 96. Hetero Pharma Business Overview

Table 97. Hetero Pharma Pediatric Influenza Treatment Product

Table 98. Hetero Pharma Revenue in Pediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 99. Hetero Pharma Recent Developments

Table 100. Teva Pharmaceutical pvt. Ltd. Company Details

Table 101. Teva Pharmaceutical pvt. Ltd. Business Overview

Table 102. Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Product

Table 103. Teva Pharmaceutical pvt. Ltd. Revenue in Pediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 104. Teva Pharmaceutical pvt. Ltd. Recent Developments

Table 105. Olainfarm JSC Company Details

Table 106. Olainfarm JSC Business Overview

Table 107. Olainfarm JSC Pediatric Influenza Treatment Product

Table 108. Olainfarm JSC Revenue in Pediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 109. Olainfarm JSC Recent Developments

Table 110. Gilead Sciences, Inc. Company Details

Table 111. Gilead Sciences, Inc. Business Overview

Table 112. Gilead Sciences, Inc. Pediatric Influenza Treatment Product

Table 113. Gilead Sciences, Inc. Revenue in Pediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 114. Gilead Sciences, Inc. Recent Developments

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pediatric Influenza Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Pediatric Influenza Treatment Market Share by Type: 2023 VS 2030

Figure 3. Antiviral Drug Features

Figure 4. Antipyretic Features

Figure 5. Neuraminidase inhibitor Features

Figure 6. Others Features

Figure 7. Global Pediatric Influenza Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Pediatric Influenza Treatment Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Ambulatory Surgical Centers Case Studies

Figure 12. Others Case Studies

Figure 13. Pediatric Influenza Treatment Report Years Considered

Figure 14. Global Pediatric Influenza Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Pediatric Influenza Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Pediatric Influenza Treatment Market Share by Region: 2023 VS 2030

Figure 17. Global Pediatric Influenza Treatment Market Share by Players in 2023

Figure 18. Global Top Pediatric Influenza Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Influenza Treatment as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Pediatric Influenza Treatment Revenue in 2023

Figure 20. North America Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Pediatric Influenza Treatment Market Share by Type (2019-2030)

Figure 22. North America Pediatric Influenza Treatment Market Share by Application (2019-2030)

Figure 23. North America Pediatric Influenza Treatment Market Share by Country (2019-2030)

Figure 24. United States Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Pediatric Influenza Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Pediatric Influenza Treatment Market Share by Type (2019-2030)

Figure 28. Europe Pediatric Influenza Treatment Market Share by Application (2019-2030)

Figure 29. Europe Pediatric Influenza Treatment Market Share by Country (2019-2030)

Figure 30. Germany Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Pediatric Influenza Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Pediatric Influenza Treatment Market Share by Type (2019-2030)

Figure 38. China Pediatric Influenza Treatment Market Share by Application (2019-2030)

Figure 39. Asia Pediatric Influenza Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Pediatric Influenza Treatment Market Share by Type (2019-2030)

Figure 41. Asia Pediatric Influenza Treatment Market Share by Application (2019-2030)

Figure 42. Asia Pediatric Influenza Treatment Market Share by Region (2019-2030)

Figure 43. Japan Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Pediatric Influenza Treatment Market Share by Country (2019-2030)

Figure 53. Brazil Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Pediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Pediatric Influenza Treatment Business (2019-2024)

Figure 60. GlaxoSmithKline Plc. Revenue Growth Rate in Pediatric Influenza Treatment Business (2019-2024)

Figure 61. NATCO Pharma Limited. Revenue Growth Rate in Pediatric Influenza Treatment Business (2019-2024)

Figure 62. NESHER PHARMS Revenue Growth Rate in Pediatric Influenza Treatment Business (2019-2024)

Figure 63. Johnson & Johnsons Inc. Revenue Growth Rate in Pediatric Influenza Treatment Business (2019-2024)

Figure 64. Cipla Revenue Growth Rate in Pediatric Influenza Treatment Business (2019-2024)

Figure 65. Hetero Pharma Revenue Growth Rate in Pediatric Influenza Treatment Business (2019-2024)

Figure 66. Teva Pharmaceutical pvt. Ltd. Revenue Growth Rate in Pediatric Influenza Treatment Business (2019-2024)

Figure 67. Olainfarm JSC Revenue Growth Rate in Pediatric Influenza Treatment Business (2019-2024)

Figure 68. Gilead Sciences, Inc. Revenue Growth Rate in Pediatric Influenza Treatment Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions